25 related articles for article (PubMed ID: 1950757)
1. Phoenix from the Ashes: Celebrating the 2023 North American Cystic Fibrosis Conference.
Bush A; Ramsey B; Shteinberg M; Martinez F
Am J Respir Crit Care Med; 2023 Nov; 208(9):909-910. PubMed ID: 37756479
[No Abstract] [Full Text] [Related]
2. Highlights of the 2010 North American Cystic Fibrosis Conference.
Southern KW
J R Soc Med; 2011 Jul; 104 Suppl 1(Suppl 1):S15-8. PubMed ID: 21719887
[No Abstract] [Full Text] [Related]
3. Highlights of the North American Cystic Fibrosis Conference 2008.
Hilliard T; Wedlock K; McGowan H; Hayward C; Downey D
J R Soc Med; 2009 Jul; 102 Suppl 1(Suppl 1):18-22. PubMed ID: 19605870
[No Abstract] [Full Text] [Related]
4. G551D and G1349D, two CF-associated mutations in the signature sequences of CFTR, exhibit distinct gating defects.
Bompadre SG; Sohma Y; Li M; Hwang TC
J Gen Physiol; 2007 Apr; 129(4):285-98. PubMed ID: 17353351
[TBL] [Abstract][Full Text] [Related]
5. Functional roles of the nucleotide-binding folds in the activation of the cystic fibrosis transmembrane conductance regulator.
Smit LS; Wilkinson DJ; Mansoura MK; Collins FS; Dawson DC
Proc Natl Acad Sci U S A; 1993 Nov; 90(21):9963-7. PubMed ID: 7694298
[TBL] [Abstract][Full Text] [Related]
6. [Principles of DNA diagnosis exemplified by cystic fibrosis].
Peinemann F; Reiss J
Monatsschr Kinderheilkd; 1991 Feb; 139(2):83-8. PubMed ID: 2038351
[TBL] [Abstract][Full Text] [Related]
7. Splice mutation 1811+1.6kbA>G causes severe cystic fibrosis with pancreatic insufficiency: report of 11 compound heterozygous and two homozygous patients.
Reboul MP; Bieth E; Fayon M; Biteau N; Barbier R; Dromer C; Desgeorges M; Claustres M; Bremont F; Lacombe D; Iron A
J Med Genet; 2002 Nov; 39(11):e73. PubMed ID: 12414835
[No Abstract] [Full Text] [Related]
8. Identification of cystic fibrosis mutations.
Dean M; Gerrard B; Stewart C; Krueger L; Holsclaw D; Quittell L; Baranov V; Kapronov N; Leppert M; Amos J
Adv Exp Med Biol; 1991; 290():45-51. PubMed ID: 1719771
[No Abstract] [Full Text] [Related]
9. Two novel frame-shift mutations: 977 insA in exon 6B, and 4016 insT in exon 21, of the cystic fibrosis transmembrane conductance regulator (CFTR) gene.
Cheadle JP; al-Jader LN; Meredith AL
Hum Mol Genet; 1993 Mar; 2(3):317-9. PubMed ID: 7684644
[No Abstract] [Full Text] [Related]
10. Prevalence of cystic fibrosis mutations in the Grampian region of Scotland.
Miedzybrodzka ZH; Dean JC; Russell G; Friend JA; Kelly KF; Haites NE
J Med Genet; 1993 Apr; 30(4):316-7. PubMed ID: 8487279
[TBL] [Abstract][Full Text] [Related]
11. Mutation analysis for cystic fibrosis in a North American population.
Beaudet AL; Feldman GL; Kobayashi K; Lemna WK; Fernbach SD; Knowles MR; Boucher RC; O'Brien WE
Adv Exp Med Biol; 1991; 290():53-4. PubMed ID: 1950757
[No Abstract] [Full Text] [Related]
12. Genetics of Cystic Fibrosis: Clinical Implications.
Egan ME
Clin Chest Med; 2016 Mar; 37(1):9-16. PubMed ID: 26857764
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
